ReviewKidney diseases (Basel, Switzerland)

Comparison of Anticoagulant Effects of Nafamostat Mesilate and Heparin in Continuous Renal Replacement Therapy for Patients with High Bleeding Risk: A Meta-Analysis Systemic Review.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.